LipidViro Tech, Inc. to Present at Financial Services Exchange Investment Conference to Discuss Potential for New Treatment for Stroke and Chronic Heart Failure

Published: Apr 27, 2007

SALT LAKE CITY, UT -- (MARKET WIRE) -- April 27, 2007 -- LipidViro Tech, Inc. (OTCBB: LPVT), a medical device company developing its proprietary d-OSAB technology for the treatment of stroke and chronic heart failure, announced that J.S. Latino, co-founder and head of research, and Linda Sharkus, Ph.D., director, are attending the Financial Services Exchange (FSX) Investment Conference being held April 26-28, 2007, at the Hilton San Francisco Financial District Hotel in San Francisco.

Back to news